Frontotemporal dementia: An updated overview
2009

Overview of Frontotemporal Dementia

publication Evidence: moderate

Author Information

Author(s): E. Mohandas, V. Rajmohan

Primary Institution: Elite Mission Hospital

Conclusion

Frontotemporal dementia (FTD) is a complex disorder with no specific pharmacological treatments available, although some medications may provide modest benefits.

Supporting Evidence

  • FTD is the third most common degenerative dementia, occurring in 5-15% of dementia patients.
  • Behavioral changes are the most common initial symptom of FTD, seen in 62% of cases.
  • Genetic factors play a significant role, with 40-50% of cases having a family history of FTD.

Takeaway

Frontotemporal dementia is a brain disease that affects how people behave and think, and it usually starts between the ages of 45 and 65. There are no specific medicines to treat it yet.

Limitations

The study highlights the lack of specific pharmacological treatments and the need for further research.

Participant Demographics

FTD occurs equally in both sexes, typically starting between ages 45 and 65.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication